• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)

    28.86 -0.18 (-0.62%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about RAPT Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 Next >
    Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
    The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results... 
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Rapt Therapeutics, Outperforming 98% Of All Stocks, Skyrockets After Topping Roche
    The company took on Roche's Xolair in a 16-week study of patients with a chronic hives disorder. 
    Via Investor's Business Daily
    These stocks are moving in today's pre-market session
    As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
    Via Chartmill
    Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    There are notable gap-ups and gap-downs in today's session.
    Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session. 
    Via Chartmill
    Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position
    Clear Street’s initiated with a $3 price target, highlighting RPT904b as a “potentially best-in-class anti-IgE antibody.” 
    Via Stocktwits
    Topics ETFs
    12 Health Care Stocks Moving In Thursday's After-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
     
    Via Benzinga
    Futures Slide As Bond Yields Jump To 6 Month High
    US stock futures and Treasuries dropped as muted trading resumed after the Christmas holiday, with investors looking to initial jobless claims data and a government bond auction later on Thursday. 
    Via Talk Markets
    Topics Bonds Commodities Cryptocurrencies
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday
     
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    Why RAPT Therapeutics Stock Gained Over 100% On Monday?
    RAPT Therapeutics partners with Shanghai Jemincare to develop RPT904, a potential alternative to Xolair, for food allergies. $35M upfront payment. 
    Via Benzinga
    US Stocks Mixed, Dow Tumbles 150 Points
     
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    Crude Oil Down 3%; Aramark Posts Upbeat Earnings
     
    Via Benzinga
    Nasdaq Moves Lower; Canaan Shares Surge
     
    Via Benzinga
    Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury
    RAPT Therapeutics stock falls after halting its zelnecirnon program following FDA clinical hold. Company shifts focus. 
    Via Benzinga
    Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
     
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    10 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q2 2024
    RAPT stock results show that RAPT Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
     
    Via Benzinga
    Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
     
    Via Benzinga
    What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
    RAPT Therapeutics closes Phase 2 trials for zelnecirnon in atopic dermatitis & asthma following FDA clinical hold due to liver failure. 
    Via Benzinga
    Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
     
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.